CA9 and neoplasm: The ability of the two antibodies in SIP format to recognise the native CA IX on the surface of tumour cells was investigated by fluorescence-activated cell sorting (FACS), in comparison to a recombinant SIP antibody of irrelevant specificity (HyHEL-10; (Lavoie et al, 1992).